68Ga-PSMA PET/CT Detecting Metastatic Lesion of RCC Missed on 18F-FDG PET/CT

被引：2
|
作者：
Jha, Saurav [1 ]
Hemrom, Angel [1 ]
Shamim, Shamim Ahmed [1 ,4 ]
Barwad, Adarsh [2 ]
Batra, Atul [3 ]
机构：
[1] All India Inst Med Sci, Dept Nucl Med, New Delhi, India
[2] All India Inst Med Sci, Dept Pathol, New Delhi, India
[3] All India Inst Med Sci, Med Oncol, New Delhi, India
[4] All India Inst Med Sci, Dept Nucl Med, New Delhi 110029, India
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 06期
关键词：
renal cell carcinoma; Ga-68-PSMA; F-18-FDG PET/CT; MEMBRANE ANTIGEN; EPIDEMIOLOGY; CARCINOMA;
D O I：
10.1097/RLU.0000000000004648
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Renal cell carcinoma (RCC) accounts for similar to 2% of global cancers and deaths. Survival depends on initial staging and shows poor survival rate in metastatic disease. CT and MRI are used for evaluating RCC, and PET/CT is used for metastatic disease assessment. We report a case of RCC, where both F-18-FDG and Ga-68-PSMA PET/CT showed increased uptake in liver metastatic lesions; however, a subhepatic peritoneal deposit showed uptake only in PSMA. Also, liver lesions were seen better in PSMA owing to lesser background uptake, suggesting a possibility of Ga-68-PSMA being a potential tracer for RCC evaluation.
引用
收藏
页码：E294 / E296
页数：3
相关论文
共 50 条
  • [1] 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma
    Chen, Ew-Jun
    Tan, Teik Hin
    Chew, Ming Tsuey
    Chye, Ping Ching
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : E317 - E319
  • [2] Comparison of 68Ga-PSMA and 18F-FDG PET/CT in metastatic workup of Renal Cell Carcinoma (RCC)
    Jha, Saurav
    Kumar, Naresh
    Shamim, Shamim Ahmed
    Bal, Chandrasekhar
    Batra, Atul
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [3] 18F-FDG and 68Ga-PSMA PET/CT in Paratesticular Mesothelioma
    Kalantari, Forough
    Schweighofer-Zwink, Gregor
    Rendl, Gundula
    Pirich, Christian
    Beheshti, Mohsen
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (04) : 332 - 332
  • [4] 68Ga-PSMA PET/CT and 18F-FDG PET/CT in the diagnosis of prostatic ductal cancer
    Huang, Haijun
    Zou, Sijuan
    Wan, Jie
    Zeng, Xing
    Wang, Shaogang
    Hu, Zhiquan
    Zhu, Xiaohua
    Yang, Chunguang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 448E9 - 448E16
  • [5] 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
    Gundogan, Cihan
    Ergul, Nurhan
    Cakir, Mehmet Semih
    Kilickesmez, Ozgur
    Gursu, Riza Umar
    Aksoy, Tamer
    Cermik, Tevfik Fikret
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 79 - 85
  • [6] A Comparison of 18F-FDG PET/CT and 68Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer
    Ozturk, Ahmet Ertugrul
    Sahin, Rahime
    Ergul, Nurhan
    Cermik, Tevfik Fikret
    Arslan, Esra
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : e68 - e69
  • [7] Comparison of 18F-FDG PET-CT and 68GA-PSMA PET-CT in Hepatocellular Carcinoma
    Shamim, S.
    Arora, G.
    Hussain, J.
    Gupta, S.
    Shalimar
    Gamanagatti, S.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S556 - S557
  • [8] 68Ga-PSMA Versus 18F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma
    Senses, Veysi
    Kaplan, Ihsan
    Kaya, Fulya
    Ibiloglu, Ibrahim
    Can, Canan
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : e464 - e467
  • [9] PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma Report of 2 Cases
    Isgoren, Serkan
    Hekimsoy, Turkay
    Koroglu, Erdem
    Demir, Hakan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) : E423 - E424
  • [10] Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT
    Parida, Girish Kumar
    Tripathy, Sarthak
    Gupta, Shreya Datta
    Singhal, Abhinav
    Kumar, Rakesh
    Bal, Chandrasekhar
    Shamim, Shamim Ahmed
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 248 - 249
12345